Laura Schulz, CEO of Ghost Medical, sat down with Kelli Hanson on Twin Cities LIVE Today to share her inspiring story of resilience and innovation. During the interview, Laura opened up about her personal experience with cancer and her decision to participate in a clinical trial, shedding light on how trials contribute to medical advancements that benefit generations to come.
For Laura, the journey began with a cancer diagnosis that shifted her focus from running a company dedicated to advancing medical education to becoming an active participant in the very innovation her team helps communicate. As the CEO of Ghost Medical, a medical marketing and training company, Laura has spent years leading efforts to visually explain complex medical breakthroughs through medical animation, medical illustration, surgical VR simulations and other forms of medical interactive media. Her decision to join a clinical trial reflects not only her desire to seek the most advanced treatment options but also her deep commitment to supporting progress in healthcare.
“In my role at Ghost Medical, I’ve always seen the incredible impact of clinical trials in advancing medicine. Being part of one has been a powerful way to contribute not only to my own care but also to the future of cancer treatment,” Laura shared during the interview.
Laura emphasized the importance of clinical trials in her conversation with Kelli Hanson, highlighting their role as the backbone of medical innovation. Trials not only provide participants with access to cutting-edge treatments but also serve as the foundation for breakthroughs that can transform healthcare on a global scale.
“Every treatment available today was once part of a clinical trial,” Laura explained. “Participating in a trial is both a privilege and a responsibility, and it’s an opportunity to make a lasting impact on medicine.”
During the interview, Laura encouraged others to consider clinical trials as part of their treatment journey, addressing common misconceptions and fears. She spoke about the rigorous safety measures in place and the transformative potential of trial participation—not only for individual patients but for future generations.
“It’s deeply humbling to think that my participation might help pave the way for new treatments that make cancer less devastating for others. It’s a legacy I’m proud to be part of,” she said.
Laura’s participation in the clinical trial has also deepened her connection to the mission of Ghost Medical. “At Ghost, our mission is to explain medicine and its benefits to humanity. Being part of this trial has given me firsthand insight into the incredible effort and collaboration that goes into every medical breakthrough. It’s an experience that I’ll carry with me forever.”
Don’t miss this powerful conversation! Watch Laura Schulz’s interview with Kelli Hanson on Twin Cities Live to hear more about her cancer journey, her role in advancing medical innovation, and her advocacy for clinical trials.
This medical animation illustrates the mechanism of action of Imlunestrant, an oral medication used to treat estrogen receptor-positive (ER+) breast cancer. It also draws a connection to the drug that played a role in Laura's cancer journey.
Ghost Medical is an award-winning leader in medical visualization, specializing in custom medical animation, medical marketing services, and surgical training solutions. We provide a comprehensive range of digital services designed to elevate medical marketing, enhance patient communication, and streamline staff training. With a team of highly skilled professionals and deep expertise in biomedical processes, we ensure precise and impactful representations of your device, product, or procedure through 3D animations, medical illustration, and other dynamic media formats. Contact Ghost Medical today to discover how we can help you train surgeons, boost medical device sales, or effectively communicate your pharmaceutical innovations.
Start a Project
© 2024 Ghost Productions, Inc.
